ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

In Brief: Hood to form Institute for Systems Biology, To Unite Biologists, High-Tech Industry

December 17, 1999

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Interview With Screening Expert Barnett Kramer, PLCO Investigator

March 20, 2009

ASCO Releases Guideline On Larynx Preservation

July 28, 2006